Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS

Journal of Virology

Volumn 72, Issue 11, 1998, Pages 9069-9078

  Joag, Sanjay V ^a   Liu, Zhen Qian ^a   Stephens, Edward B ^a   Smith, Marilyn S ^a   Kumar, Anil ^a   Li, Zhuang ^a   Wang, Chunyang ^a   Sheffer, Darlene ^a   Jia, Fenglan ^a   Foresman, Larry ^a   Adany, Istvan ^a   Lifson, Jeff ^b   McClure, Harold M ^c   Narayan, Opendra ^a,d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; INFECTION PREVENTION; MACACA; NONHUMAN; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VIRUS ATTENUATION; VIRUS TRANSMISSION;

EID: 3543148237     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.11.9069-9078.1998     Document Type: Article

References (32)

1. Almond, N., K. Kent, M. Cranage, E. Rud, B. Clarke, and E. J. Stott. 1995. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344.
2. Beisinger, B., I. Muller-Fleckenstein, B. Simmer, G. Lang, S. Wittman, E. Platzer, R. C. Desrosiers, and B. Fleckenstein. 1992. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 89:3116-3119.
3. Buge, S. L., R. Richardson, S. Alipanah, P. Markham, S. Cheng, N. Kalyan, C. J. Miller, M. Lubeck, S. Udem, J. Eldridge, and M. Robert-Guroff. 1997. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge. J. Virol. 71:8531-8541.
4. Chun, T. W., L. Stuyver, S. B. Mizell, L. A. Ehler, J. A. M. Mican, M. Baseler, A. L. Lloyd, M. A. Nowak, and A. S. Fauci. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193-13197.
5. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
6. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
7. Foresman, L., F. Jia, Z. Li, C. Wang, E. B. Stephens, M. Sahni, O. Narayan, and S. V. Joag. 1998. Neutralizing antibodies administered before but not after virulent SHIV prevent infection in macaques. AIDS Res. Hum. Retroviruses 14:1035-1043.
8. Gunthard, H. F., J. K. Wong, C. C. Ignacio, J. C. Guatelli, N. L. Riggs, D. V. Havlir, and D. D. Richman. 1998. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72:2422-2428.
9. + T cells, and AIDS. J. Virol. 71: 4016-4023.
10. mac239 during persistent infection in a rhesus macaque. Virology 195:406-412.
11. Joag, S. V., Z. Li, L. Foresman, D. Pinson, R. Raghavan, W. Zhuge, I. Adany, C. Wang, F. Jia, D. Sheffer, J. Ranchalis, A. Watson, and O. Narayan. 1997. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res. Hum. Retroviruses 13:635-645.
12. + T cells and AIDS in pigtailed macaques. J. Virol. 70:3189-3197.
13. Joag, S. V., Z. Li, C. Wang, L. Foresman, F. Jia, E. B. Stephens, and O. Narayan. Passively administered neutralizing serum which protected macaques against infection with parenterally-inoculated pathogenic SHIV failed to protect against mucosally-inoculated virus. Submitted for publication.
14. mac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200:436-446.
15. Lennette, E. H. 1969. General principles underlying laboratory diagnosis of viral and rickettsial infections, p. 1-65. In E. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral and rickettsial infections. American Public Health Association, New York, N.Y.
16. Li, J., C. I. Lord, W. Haseltine, N. L. Letvin, and J. Sodroski. 1992. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmacX virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immune Defic. Syndr. 5:639-646.
17. McCormick-Davis, C., L. Zhao, S. Mukherjee, K. Leung, D. Sheffer, S. V. Joag, O. Narayan, and E. B. Stephens. 1998. Chronology of genetic changes in the vpu, env and nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques. Virology 248:275-283.
18. Merkenschlager, M., D. Buck, P. C. Beverley, and Q. J. Sattentau. 1990. Functional epitope analysis of the human CD4 molecule. The MHC class II-dependent activation of resting T cells is inhibited by monoclonal antibodies to CD4 regardless whether or not they recognize epitopes involved in the binding of MHC class II or HIV gp120. J. Immunol. 145:2839-2845.
19. Musey, L., J. Hughes, T. Schacker, T. Shea, L. Corey, and M. J. McElrath. 1997. Cytotoxic-T-cell responses, viral load and disease progression in early human immunodeficiency virus type 1 infection. N. Engl. J. Med. 337:1267-1274.
20. Narayan, O., and H. M. McClure. Unpublished data.
21. Saksela, K., E. Muchmore, M. Girard, P. Fultz, and D. Baltimore. 1993. High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J. Virol. 67: 7423-7427.
22. Sharpe, S. A., A. M. Whatmore, G. A. Hall, and M. P. Cranage. 1997. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus. J. Gen. Virol. 78:1923-1927.
23. Smith, M. S., C. Bloomer, R. Horvat, E. Goldstein, J. M. Casparian, and B. Chandran. 1997. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J. Infect. Dis. 176: 84-93.
24. Stahl Hennig, C., T. Dittmer, T. Nisslein, H. Petry, E. Jurkiewicz, D. Fuchs, H. Wachter, K. Matz-Rensing, E. M. Kuhn, F. J. Kaup, E. W. Rud, and G. Hunsmann. 1996. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J. Gen. Virol. 77:2969-2981.
25. KU-1. Virology 234:328-339.
26. Stephens, E. B., S. V. Joag, D. Sheffer, Z. Q. Liu, L. Zhao, S. Mukherjee, L. Foresman, I. Adany, Z. Li, D. M. Pinson, and O. Narayan. 1996. Initial characterization of viral sequences from a SHIV-inoculated pigtailed macaque that developed AIDS. J. Med. Primatol. 25:175-185.
27. smmPBj14 causes PBj-like activation of cultured resting peripheral blood mononuclear cells, but the chimera showed no increase in virulence. J. Virol. 72:5207-5214.
28. mac and HIV-1 regions of the genome and has altered cytotropism. Virology 231:313-321.
29. Suryanarayana, K., T. A. Wiltrout, G. M. Vasquez, V. M. Hirsch, and J. D. Lifson. 1998. Plasma SIV RNA viral load by real time quantification of product generation in RT PCR. AIDS Res. Hum. Retroviruses 14:183-189.
30. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
31. Wyand, M. S., K. H. Manson, M. Garcia Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.
32. mac and not observed with neutralization of SHIV or HIV-1. AIDS Res. Hum. Retroviruses 14:1045-1051.